Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus
Glucose-lowering medication and lifestyle modification are essential for optimal glycemic control in patients with type 2 diabetes mellitus (T2DM). However, glucose-lowering agents, particularly insulin and insulin secretagogues, may cause hypoglycemia, which has multiple negative effects on the car...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Association of Internal Medicine
2021-03-01
|
Series: | The Korean Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.kjim.org/upload/pdf/kjim-2020-327.pdf |
id |
doaj-31f2ecd459284bf9846c07fc40d9e108 |
---|---|
record_format |
Article |
spelling |
doaj-31f2ecd459284bf9846c07fc40d9e1082021-08-10T04:41:15ZengThe Korean Association of Internal MedicineThe Korean Journal of Internal Medicine1226-33032005-66482021-03-0136226327010.3904/kjim.2020.327170468Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitusSoo-Yeon Choi0Seung-Hyun Ko1Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, KoreaGlucose-lowering medication and lifestyle modification are essential for optimal glycemic control in patients with type 2 diabetes mellitus (T2DM). However, glucose-lowering agents, particularly insulin and insulin secretagogues, may cause hypoglycemia, which has multiple negative effects on the cardiovascular (CV) system and may cause death. Previous studies using institutional data from the Korean Nationwide Health Insurance database have consistently found a causal relationship between severe hypoglycemia and CV outcomes and mortality. Screening for high-risk patients, appropriate management, and intensive individualized education are the most effective measures and essential for the prevention of harmful hypoglycemic events. Based on identified risk factors that predict severe hypoglycemia, we developed an 1-year risk prediction model for severe hypoglycemia that can be used in clinical settings. In this review, we describe the current understanding of severe hypoglycemia and the clinical implications in patients with T2DM. Furthermore, we highlight the importance of intensive individualized education for high-risk patients and the risk prediction model to reduce severe hypoglycemia.http://www.kjim.org/upload/pdf/kjim-2020-327.pdfdiabetes mellitustype 2severe hypoglycemiacardiovascular diseaseseducation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Soo-Yeon Choi Seung-Hyun Ko |
spellingShingle |
Soo-Yeon Choi Seung-Hyun Ko Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus The Korean Journal of Internal Medicine diabetes mellitus type 2 severe hypoglycemia cardiovascular diseases education |
author_facet |
Soo-Yeon Choi Seung-Hyun Ko |
author_sort |
Soo-Yeon Choi |
title |
Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus |
title_short |
Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus |
title_full |
Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus |
title_fullStr |
Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus |
title_full_unstemmed |
Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus |
title_sort |
severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus |
publisher |
The Korean Association of Internal Medicine |
series |
The Korean Journal of Internal Medicine |
issn |
1226-3303 2005-6648 |
publishDate |
2021-03-01 |
description |
Glucose-lowering medication and lifestyle modification are essential for optimal glycemic control in patients with type 2 diabetes mellitus (T2DM). However, glucose-lowering agents, particularly insulin and insulin secretagogues, may cause hypoglycemia, which has multiple negative effects on the cardiovascular (CV) system and may cause death. Previous studies using institutional data from the Korean Nationwide Health Insurance database have consistently found a causal relationship between severe hypoglycemia and CV outcomes and mortality. Screening for high-risk patients, appropriate management, and intensive individualized education are the most effective measures and essential for the prevention of harmful hypoglycemic events. Based on identified risk factors that predict severe hypoglycemia, we developed an 1-year risk prediction model for severe hypoglycemia that can be used in clinical settings. In this review, we describe the current understanding of severe hypoglycemia and the clinical implications in patients with T2DM. Furthermore, we highlight the importance of intensive individualized education for high-risk patients and the risk prediction model to reduce severe hypoglycemia. |
topic |
diabetes mellitus type 2 severe hypoglycemia cardiovascular diseases education |
url |
http://www.kjim.org/upload/pdf/kjim-2020-327.pdf |
work_keys_str_mv |
AT sooyeonchoi severehypoglycemiaasapreventableriskfactorforcardiovasculardiseaseinpatientswithtype2diabetesmellitus AT seunghyunko severehypoglycemiaasapreventableriskfactorforcardiovasculardiseaseinpatientswithtype2diabetesmellitus |
_version_ |
1721212863918374912 |